诺托金胺R1通过调节MDM2/β arrestin2-介导的β2-上腺体受体ubiquitination减弱缺血性心力衰竭
Qi Chen1, Ziwei Huang1, Jing Chen2
1Guangdong Provincial Key Laboratory of Translational Cancer Research of Chinese Medicines, Joint International Research Laboratory of Translational Cancer Research of Chinese Medicines, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
概括
诺托金化物R1 (NGR1) 通过稳定β2上腺素受体 (β2AR) 来预防慢性心力衰竭. 在心力衰竭模型中,NGR1 阻止了β2AR 降解,改善了心脏功能.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 慢性心力衰竭 (CHF) 涉及交感过度激活,导致β2上腺素受体 (β2AR) 脱敏和降低调节.
- 诺托金化物R1 (NGR1) 显示在增强心肌能量代谢和减少纤维化方面具有潜力,但其在心力衰竭中的机制尚不清楚.
研究的目的:
- 在缺血性心力衰竭的小鼠模型中阐明NGR1的保护机制.
- 研究NGR1对β2AR表达和稳定性的影响.
主要方法:
- 在C57BL/6J小鼠中通过左前下垂动脉绑定诱导缺血性心力衰竭.
- 用NGR1的不同剂量 (3,10,30毫克/公斤/天) 进行治疗,并评估心脏功能,组织学和分子标记 (ANP,β-MHC).
- 在实验室中使用H9c2细胞接受氧-葡萄糖剥夺/反 (OGD/R) 的研究,以评估NGR1的保护作用及其对β2AR,MDM2和β-arrestin2相互作用的影响.
主要成果:
- 在患有缺血性心力衰竭的小鼠中,NGR1治疗改善了心脏功能和形态.
- NGR1保护了H9c2细胞免受OGD/R诱导的损伤,增加了β2AR水平,并减少了β2AR无处不在.
- NGR1增强了MDM2的稳定性,增加了MDM2和β-arrestin2的表达,并抑制了它们的相互作用. 抑制MDM2减弱了NGR1的保护作用.
结论:
- NGR1通过防止β2AR无化和降解来预防慢性心力衰竭.
- NGR1通过调节MDM2/β-arrestin2通路来实现这一目标,从而稳定β2AR并保持心脏功能.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
01:26Heart Failure Drugs: Inotropic Agents
564
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
564
01:22Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
01:22Heart Failure Drugs: Diuretics
362
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
362
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
01:17Antihypertensive Drugs: Action of β1 Blockers
416
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
416